Systemic Therapy for Melanoma: ASCO Guideline Update
Journal of Clinical Oncology · 20.10.2023 · 41 (30) · 4794-4820
DOI: 10.1200/jco.23.01136 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of Clinical Oncology, erschienen am 20.10.2023. Verfasst von Rahul Seth und 29 weiteren Autor:innen. Beteiligte Einrichtung: SUNY Upstate Medical University, Syracuse, NY. Hauptthemen laut MEDLINE: Melanoma, Oncolytic Virotherapy, Skin Neoplasms. Die Arbeit wurde bisher 241-mal zitiert (Crossref) und nennt 127 Literaturangaben.
Abstract (Originalsprache)
PURPOSE To provide guidance to clinicians regarding the use of systemic therapy for melanoma. METHODS American Society of Clinical Oncology convened an Expert Panel and conducted an updated systematic review of the literature. RESULTS The updated review identified 21 additional randomized trials. UPDATED RECOMMENDATIONS Neoadjuvant pembrolizumab was newly recommended for patients with resectable stage IIIB to IV cutaneous melanoma. For patients with resected cutaneous melanoma, adjuvant nivolumab or pembrolizumab was newly recommended for stage IIB-C disease and adjuvant nivolumab plus ipilimumab was added as a potential option for stage IV disease. For patients with unresectable or metastatic cutaneous melanoma, nivolumab plus relatlimab was added as a potential option regardless of BRAF mutation status and nivolumab plus ipilimumab followed by nivolumab was preferred over BRAF/MEK inhibitor therapy. Talimogene laherparepvec is no longer recommended as an option for patients with BRAF wild-type disease who have progressed on anti–PD-1 therapy. Ipilimumab- and ipilimumab-containing regimens are no longer recommended for patients with BRAF-mutated disease after progression on other therapies. This full update incorporates the new recommendations for uveal melanoma published in the 2022 Rapid Recommendation Update. Additional information is available at www.asco.org/melanoma-guidelines .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- SUNY Upstate Medical University, Syracuse, NY.
- Lewis Katz School of Medicine at Temple University, Philadelphia, PA.
- American Society of Clinical Oncology, Alexandria, VA.
- St Luke's Mountain States Tumor Institute, Boise, ID.
- Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.
- Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC.
ORCID-Profile: Hans Messersmith, Krishna C Alluri, Paolo A Ascierto, Michael B Atkins, Kathryn Bollin, Matias Chacon, Nancy Davis, Mark B Faries, Pauline Funchain, Jason S Gold, David E Gyorki, Varinder Kaur, Nikhil I Khushalani, John M Kirkwood, Jennifer Leigh McQuade, Michael O Meyers, Caroline Robert, Mario Santinami, Vernon K Sondak, Umang Swami, Alexander van Akkooi, Jeffrey Weber
Zitieren
APA
Seth, R., Agarwala, S. S., Messersmith, H., Alluri, K. C., Ascierto, P. A., Atkins, M. B., Bollin, K., Chacon, M., Davis, N., Faries, M. B., Funchain, P., Gold, J. S., Guild, S., Gyorki, D. E., Kaur, V., Khushalani, N. I., Kirkwood, J. M., McQuade, J. L., Meyers, M. O., …, & Weber, J. (2023). Systemic Therapy for Melanoma: ASCO Guideline Update. Journal of Clinical Oncology, 41(30), 4794-4820. https://doi.org/10.1200/jco.23.01136
Vancouver
Seth R, Agarwala SS, Messersmith H, Alluri KC, Ascierto PA, Atkins MB, et al. Systemic Therapy for Melanoma: ASCO Guideline Update. Journal of Clinical Oncology. 2023;41(30):4794-4820. doi:10.1200/jco.23.01136
BibTeX
@article{Seth2023,
author = {Seth, Rahul and Agarwala, Sanjiv S and Messersmith, Hans and Alluri, Krishna C and Ascierto, Paolo A and Atkins, Michael B and Bollin, Kathryn and Chacon, Matias and Davis, Nancy and Faries, Mark B and Funchain, Pauline and Gold, Jason S and Guild, Samantha and Gyorki, David E and Kaur, Varinder and Khushalani, Nikhil I and Kirkwood, John M and McQuade, Jennifer Leigh and Meyers, Michael O and Provenzano, Anthony and Robert, Caroline and Santinami, Mario and Sehdev, Amikar and Sondak, Vernon K and Spurrier, Gilliosa and Swami, Umang and Truong, Thach-Giao and Tsai, Katy K and van Akkooi, Alexander and Weber, Jeffrey},
title = {Systemic Therapy for Melanoma: ASCO Guideline Update},
journal = {Journal of Clinical Oncology},
year = {2023},
volume = {41},
number = {30},
pages = {4794--4820},
doi = {10.1200/jco.23.01136}
}
EUVIMED